Active

Benno Therapeutics

Switched

BE1006661347

Rechtspersoon Private limited company 1 establishment

Ambachtenlaan 1, 3001 Leuven Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

2 year, 6 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -194,008

Profit

Caution

€ -790,201

Debts

High

€ 563,483

Benno Therapeutics from Leuven, company number BE1006661347, closed financial year 2025 with a result of € -790,201 after tax. For that financial year Benno Therapeutics recorded a gross margin of € -194,008 and equity of € -506,759. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What happened at Benno Therapeutics?

What happened at Benno Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 790,201. Source: NBB ↗
  • New establishment in Leuven. KBO
  • Donna Investco BV became a director. NBB
  • Start of the company according to the CBE. KBO

A new publication or filing at Benno Therapeutics? We notify you, reason included.

Follow Benno Therapeutics

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Donna Investco BV
Benno Therapeutics

Behind Benno Therapeutics is Donna Investco BV.

See the full network in the app

Directors

According to the 2025 annual accounts

Donna Investco BV

Statutair Bestuurder · represented by Erwin Blomsma, Raymond Perrenet

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Ambachtenlaan 1

3001 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

Details

Company number
1006.661.347
VAT number
BE 1006.661.347
Registered office
Ambachtenlaan 1, 3001 Leuven
Names & denominations
Benno Therapeutics · Benno of BennoTX
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 March 2024
Peppol
Active · Active since 30 Oct 2025
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Diensten in verband met de verzorging van huisdieren, muv veterinaire diensten

Diensten in verband met de verzorging van huisdieren, m.u.v. veterinaire diensten

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Frequently asked questions

What is the enterprise number of Benno Therapeutics?
The enterprise number of Benno Therapeutics is BE1006661347.
What is the address of Benno Therapeutics?
The registered office of Benno Therapeutics is located at Ambachtenlaan 1, 3001 Leuven.
When was Benno Therapeutics founded?
Benno Therapeutics was founded on 1 March 2024.
What is the main activity of Benno Therapeutics?
The main activity of Benno Therapeutics is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does Benno Therapeutics have a website?
No website is currently known for Benno Therapeutics.
How much profit did Benno Therapeutics make in 2025?
Benno Therapeutics recorded a loss after taxes of € 790,201 in financial year 2025.
What is the revenue of Benno Therapeutics?
As a small company, Benno Therapeutics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -194,008.
Where can I find the annual accounts of Benno Therapeutics?
Benno Therapeutics files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Benno Therapeutics?
According to the 2025 annual accounts, the directors of Benno Therapeutics are: Donna Investco BV.
Who owns Benno Therapeutics?
Behind Benno Therapeutics is Donna Investco BV.